Related Experiment Video

Updated: Aug 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Pneumonia - pathogen-based or constellation-based therapy?]

A Kuhnke1, T Welte, N Suttorp

  • 1Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie, Charite, Campus Virchow Klinikum, Augustenburger Platz 1, 13 353 Berlin. antje.kuhnke@charite.de

Der Internist
|June 15, 2006
PubMed

Insights

Community-acquired pneumonia (CAP) requires prompt antibiotic therapy. Treatment choice for CAP must balance suspected pathogens and patient-specific risk factors for improved outcomes.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Context:

  • Community-acquired pneumonia (CAP) is a leading cause of infectious disease morbidity and mortality.
  • Accurate pathogen identification is often delayed at symptom onset.
  • Effective antibiotic selection is critical for patient prognosis.

Purpose:

  • To outline the critical factors influencing initial antibiotic selection for CAP.
  • To emphasize the shift from pathogen-based to constellation-based treatment strategies.

Summary:

  • Early and adequate antibiotic treatment is vital for CAP patients.
  • Antibiotic choice depends on suspected pathogens, local resistance patterns, and individual patient risk factors (age, severity, comorbidities, prior treatment).
  • Treatment should transition from pathogen-based to constellation-based approaches.

Impact:

  • Optimizing antibiotic selection can improve patient survival rates for CAP.
  • This approach aids clinicians in making informed treatment decisions for CAP.
  • Reduces mortality and morbidity associated with this common infection.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: